GLP-1 analogues, including Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide, present diverse choices for individuals seeking effective weight management solutions
It is associated with insulin resistance as seen in type 2 diabetes mellitus
If you are unable to keep fluids down, you should seek prompt medical attention
Chronic diarrhea persisting beyond four weeks, even if mild, requires investigation to exclude conditions such as microscopic colitis, bile acid malabsorption, or exocrine pancreatic insufficiency
Currently, there are many studies focusing on more effective treatment of obesity and co-morbidities
Retatrutide is a next-generation weight loss injection developed by Eli Lilly (same manufacturer as Mounjaro), designed to target three separate hormone receptors in the body: the GLP-1 receptor, the GIP receptor, and the glucagon receptor